Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Shepherd

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Atherosclerosis. Supplements|November 9, 2004
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995James Shepherd, Stuart M Cobbe, Ian Ford, et al.
Diabetes|March 31, 2007
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factorNaveed Sattar, Alex McConnachie, Ian Ford, et al.
Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Lancet (London, England)|January 16, 2007
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyScott W Brouilette, Jasbir S Moore, Alex D McMahon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Atherosclerosis|July 18, 2002
Regulation of small dense LDL concentration in Korean and Scottish men and womenHong Keun Cho, Gilja Shin, Sung Kee Ryu, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 18, 2011
The incidence and risk factors for new onset atrial fibrillation in the PROSPER studyPeter W Macfarlane, Heather Murray, Naveed Sattar, et al.
Archives of Internal Medicine|November 26, 2008
Statins and blood pressureStella Trompet, J Wouter Jukema, Ian Ford, et al.
AIDS (London, England)|February 18, 2015
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysisTaraz Samandari, Tefera B Agizew, Samba Nyirenda, et al.
Diabetes Care|May 30, 2006
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) studyJames Shepherd, Philip Barter, Rafael Carmena, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Atherosclerosis. Supplements|November 9, 2004
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995James Shepherd, Stuart M Cobbe, Ian Ford, et al.
Diabetes|March 31, 2007
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factorNaveed Sattar, Alex McConnachie, Ian Ford, et al.
Journal of the American College of Cardiology|April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Lancet (London, England)|January 16, 2007
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control studyScott W Brouilette, Jasbir S Moore, Alex D McMahon, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) studyJames Shepherd, John J P Kastelein, Vera Bittner, et al.
Atherosclerosis|July 18, 2002
Regulation of small dense LDL concentration in Korean and Scottish men and womenHong Keun Cho, Gilja Shin, Sung Kee Ryu, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 18, 2011
The incidence and risk factors for new onset atrial fibrillation in the PROSPER studyPeter W Macfarlane, Heather Murray, Naveed Sattar, et al.
Archives of Internal Medicine|November 26, 2008
Statins and blood pressureStella Trompet, J Wouter Jukema, Ian Ford, et al.
AIDS (London, England)|February 18, 2015
Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysisTaraz Samandari, Tefera B Agizew, Samba Nyirenda, et al.
Diabetes Care|May 30, 2006
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) studyJames Shepherd, Philip Barter, Rafael Carmena, et al.
Pageof 11